From Nasdaq: 2025-02-07 17:50:08

Organon (OGN) closed at $14.62, down 1.81% from the previous day, underperforming the S&P 500, which lost 0.95%. In the past month, OGN dropped by 6.94%, trailing the Medical sector’s 5.16% gain and the S&P 500’s 1.86% increase.

Organon’s upcoming earnings release on February 13, 2025, projects an EPS of $0.86, a 2.27% decrease from last year. Analyst estimate revisions can impact stock prices, with Organon currently holding a Zacks Rank #3 (Hold).

With a Forward P/E ratio of 3.7 and a PEG ratio of 0.78, Organon is trading at a discount compared to its industry average. The Medical Services industry ranks in the bottom 28% of all industries, with the top 50% rated industries outperforming the bottom half by 2 to 1.

As global leaders commit to tripling nuclear energy capacities, investors can profit from this growing sector. Download the free report “Atomic Opportunity: Nuclear Energy’s Comeback” to explore key players and technologies driving this opportunity and discover standout stocks poised for growth.



Read more at Nasdaq: Why Organon (OGN) Dipped More Than Broader Market Today